Your browser doesn't support javascript.
loading
Cutaneous Components Leading to Pruritus, Pain, and Neurosensitivity in Atopic Dermatitis: A Narrative Review.
Ständer, Sonja; Luger, Thomas; Kim, Brian; Lerner, Ethan; Metz, Martin; Adiri, Roni; Canosa, Juliana M; Cha, Amy; Yosipovitch, Gil.
Affiliation
  • Ständer S; Center for Chronic Pruritus, Münster University Hospital, Münster, Germany. Sonja.Staender@ukmuenster.de.
  • Luger T; University Hospital Münster, Münster, Germany.
  • Kim B; Center for the Study of Itch and Sensory Disorders, Washington University School of Medicine, St. Louis, MO, USA.
  • Lerner E; Massachusetts General Hospital, Charlestown, MA, USA.
  • Metz M; Institute of Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Adiri R; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
  • Canosa JM; Pfizer Pharmaceuticals Israel Ltd, Herzliya Pituach, Israel.
  • Cha A; Pfizer Brasil Ltda, São Paulo, SP, Brazil.
  • Yosipovitch G; Pfizer Inc, New York, NY, USA.
Dermatol Ther (Heidelb) ; 14(1): 45-57, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38182845
ABSTRACT
Atopic dermatitis (AD) is a chronic, relapsing immunoinflammatory skin condition characterized by sensations such as pruritis, pain, and neuronal hypersensitivity. The mechanisms underlying these sensations are multifactorial and involve complex crosstalk among several cutaneous components. This review explores the role these components play in the pathophysiology of atopic dermatitis. In the skin intercellular spaces, sensory nerves interact with keratinocytes and immune cells via myriad mediators and receptors. These interactions generate action potentials that transmit pruritis and pain signals from the peripheral nervous system to the brain. Keratinocytes, the most abundant cell type in the epidermis, are key effector cells, triggering crosstalk with immune cells and sensory neurons to elicit pruritis, pain, and inflammation. Filaggrin expression by keratinocytes is reduced in atopic dermatitis, causing a weakened skin barrier and elevated skin pH. Fibroblasts are the main cell type in the dermis and, in atopic dermatitis, appear to reduce keratinocyte differentiation, further weakening the skin barrier. Fibroblasts and mast cells promote inflammation while dermal dendritic cells appear to attenuate inflammation. Inflammatory cytokines and chemokines play a major role in AD pathogenesis. Type 2 immune responses typically generate pruritis, and the type 1 and type 3 responses generate pain. Type 2 responses and increased skin pH contribute to barrier dysfunction and promote dysbiosis of the skin microbiome, causing the proliferation of Staphyloccocus aureus. In conclusion, understanding the dynamic interactions between cutaneous components in AD could drive the development of therapies to improve the quality of life for patients with AD.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Patient_preference Language: En Journal: Dermatol Ther (Heidelb) Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Patient_preference Language: En Journal: Dermatol Ther (Heidelb) Year: 2024 Document type: Article Affiliation country: Country of publication: